Recombinant Protein Market Report by Product (Antibodies, Hormones, Growth Factors, Cytokines, and Others), Application (Drug Discovery and Development, Academic Research, Biotechnology Research, Biopharmaceutical Production, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Contract Research Organization, and Others), and Region 2025-2033

Recombinant Protein Market Report by Product (Antibodies, Hormones, Growth Factors, Cytokines, and Others), Application (Drug Discovery and Development, Academic Research, Biotechnology Research, Biopharmaceutical Production, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Contract Research Organization, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6079

Market Overview:

The global recombinant protein market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.55% during 2025-2033.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 2.1 Billion
Market Forecast in 2033
USD 5.0 Billion
Market Growth Rate 2025-2033 9.55% 


A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Antibodies
  • Hormones
  • Growth Factors
  • Cytokines
  • Others
     

Breakup by Application:

  • Drug Discovery and Development
  • Academic Research
  • Biotechnology Research
  • Biopharmaceutical Production
  • Others
     

Breakup by End User:

  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organization
  • Others
     

Breakup by Region:

Recombinant Protein Market By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa


Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A., Thermo Fisher Scientific
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global recombinant protein market was valued at USD 2.1 Billion in 2024.

We expect the global recombinant protein market to exhibit a CAGR of 9.55% during 2025-2033.

The rising prevalence of several chronic diseases, along with the increasing demand for recombinant protein variants, such as kinase proteins, human insulin, adhesion molecules and receptors, etc., across biopharmaceutical companies and contract research organizations, is primarily driving the global recombinant protein market.

The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of recombinant protein for developing novel therapies to combat the spread of the coronavirus infection.

Based on the application, the global recombinant protein market has been segregated into drug discovery and development, academic research, biotechnology research, biopharmaceutical production, and others. Among these, drug discovery and development currently exhibits clear dominance in the market.

Based on the end user, the global recombinant protein market can be bifurcated into pharmaceutical and biopharmaceutical companies, biotechnology companies, academic and research institutes, contract research organization, and others. Currently, pharmaceutical and biopharmaceutical companies hold the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global recombinant protein market include Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A., and Thermo Fisher Scientific.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Recombinant Protein Market Report by Product (Antibodies, Hormones, Growth Factors, Cytokines, and Others), Application (Drug Discovery and Development, Academic Research, Biotechnology Research, Biopharmaceutical Production, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Contract Research Organization, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials